Guangdong CREC Carbapenemase Gene Transmission

Carbapenem-resistant Enterobacter cloacae (CREC) is an important component of the broader carbapenem-resistant Enterobacteriaceae problem. The reference study by Chen and colleagues, published in BMC Microbiology, examines how carbapenemase-encoding genes (CEGs) are distributed between plasmids and chromosomes, how readily they transfer, and whether related CREC strains occur across hospitals and clinical departments. The work is especially relevant to post-pandemic resistance surveillance because antibiotic exposure, disrupted healthcare services, and complex infections may alter opportunities for selection and transmission.

The study is available as Chen et al., BMC Microbiology (2025), 25:667. Rather than treating carbapenem resistance as a single phenotype, the investigators combine gene detection, plasmid elimination, antimicrobial susceptibility testing, conjugation, mobile-element analysis, and fingerprinting. This layered design is the central strength of the paper.

Study Background and Research Question

Carbapenem resistance in E. cloacae can arise through several mechanisms, but transferable carbapenemase genes are particularly concerning because they can move between bacterial cells independently of the original chromosomal background. A resistant isolate may therefore represent both a clinical treatment challenge and a reservoir of mobile resistance determinants.

The research question was practical and epidemiological: among CREC isolates collected from eight teaching hospitals in Guangdong Province between December 2022 and June 2024, which CEGs were present, where were they located, how efficiently could they transfer, and did molecular typing indicate dissemination of related strains across institutional or departmental boundaries? The sampling frame and study period are described in the reference article.

Key Innovation from the Reference Study

The paper’s innovation lies in integrating three transmission layers. First, plasmid elimination combined with PCR was used to infer whether a target gene was associated with plasmid DNA, chromosomal DNA, or both. Second, conjugation assays tested whether those determinants could move horizontally into a recipient strain. Third, ERIC-PCR and NTSYS analysis assessed the relatedness of the bacterial hosts, providing a way to distinguish repeated spread of a clone from independent acquisition of a mobile gene.

This distinction matters. A high frequency of a resistance gene does not by itself prove that the same strain is spreading. Conversely, genetically related isolates may disseminate even when their resistance genes occupy different molecular contexts. By considering gene location, transfer phenotype, mobile genetic elements, and strain fingerprints together, the investigators connect molecular mechanism with hospital epidemiology without equating these different processes.

Methods and Experimental Design Insights

The study analyzed 54 CREC strains obtained from the participating hospitals. The experimental workflow was designed to move from broad detection to increasingly specific interpretation. PCR identified selected carbapenemase genes; broth microdilution compared antimicrobial susceptibility patterns; plasmid conjugation tested transfer; and ERIC-PCR provided a strain-level fingerprinting framework. The methods and analytical sequence are detailed in the published study.

Protocol Parameters

• Sampling frame: The study used 54 CREC isolates from eight teaching hospitals in Guangdong, collected from December 2022 through June 2024. These values describe the literature dataset rather than a universal sampling requirement.
• Plasmid localization: Variable-temperature SDS plasmid elimination was followed by PCR. For replication, interpretation should distinguish loss of an amplifiable plasmid-associated signal from definitive physical mapping of a gene.
• Antimicrobial susceptibility: Broth microdilution was used to compare CEG-positive and CEG-negative groups. A laboratory workflow should retain the study’s comparative structure and define interpretive breakpoints before analysis.
• Conjugation testing: Plasmid conjugation experiments followed by PCR assessed whether CEGs were transferable. Transfer frequency under assay conditions should not be interpreted as a direct estimate of transmission frequency in patients or hospitals.
• Mobile-element analysis: Six mobile genetic element types were examined, with ISEcp1 reported most frequently. Replication should document primer targets and controls because mobile-element associations can depend on the genomic regions selected for PCR.
• Strain relatedness: ERIC-PCR profiles were analyzed with NTSYS software. This approach is useful for screening relatedness across isolates, while whole-genome sequencing would generally provide finer resolution when available.

One methodological advantage is the use of orthogonal evidence. PCR alone establishes the presence of a gene, whereas plasmid elimination and conjugation address its likely location and mobility. Likewise, susceptibility testing connects genotype to phenotype, while ERIC-PCR places individual isolates within a broader transmission pattern. The design therefore supports cautious mechanistic inference even without relying on a single assay.

Core Findings and Why They Matter

CEGs were detected in 46 of 54 isolates, corresponding to 85.19%, according to the reference study. The dominant pattern involved bla_NDM-1. Eighteen isolates carried this gene on both chromosomes and plasmids, while 25 carried it exclusively on plasmids. Two isolates contained only a plasmid-associated bla_IMP gene, and one carried both plasmid-associated bla_NDM-1 and bla_KPC-2. These distributions show why plasmid-versus-chromosome location is epidemiologically informative: a plasmid-borne determinant has a direct route for horizontal movement that a purely chromosomal determinant generally lacks.

The CEG-positive group also showed significantly higher resistance rates to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin than the CEG-negative group, with statistical significance reported at P<0.05 in the study. The result does not mean that every resistance phenotype is caused by the detected CEGs; resistance can involve porin changes, efflux, target modification, and additional acquired genes. It does, however, support the value of treating CEG status as a marker of broader multidrug-resistance risk in this collection.

Transfer experiments provided the most direct evidence for horizontal dissemination. CEG transfer succeeded for 44 of 46 CEG-positive isolates, or 95.65%. The reported success rates were 42 of 44 for bla_NDM-1, 2 of 2 for bla_IMP, and 0 of 1 for bla_KPC-2, as reported in the reference paper. The small numbers for bla_IMP and bla_KPC-2 require restraint, but the pattern for bla_NDM-1 supports a substantial conjugative potential under the experimental conditions.

Mobile-element data further strengthened the transmission interpretation. ISEcp1 occurred in 47 of 54 isolates, or 87.04%, and isolates carrying four mobile-element types simultaneously formed the largest category at 22 of 54, or 40.74%. These findings are consistent with a genomic environment capable of rearrangement and mobilization, although PCR detection of an element does not alone establish that it is actively mediating transfer.

ERIC-PCR and NTSYS grouped the 54 isolates into 17 genotypes. Types E and G were each represented by 11 isolates, or 20.37%, and occurred in different departments across five hospitals. Two type E isolates shared a Dice coefficient of 100%. The authors’ epidemiological analysis also found the highest detection frequencies among male patients, older individuals, respiratory-medicine departments, and sputum specimens. These observations can guide targeted surveillance, but they should not be interpreted as evidence that sex, age, or department independently causes CEG carriage.

Comparison with Existing Internal Articles

The internal article Plasmid-Mediated Carbapenemase Spread in CREC: Insights from Guangdong emphasizes the same broad interpretation: plasmid-associated bla_NDM-1 and efficient horizontal transfer are central concerns. The reference study adds methodological depth by pairing that interpretation with chromosomal-versus-plasmid analysis, susceptibility comparisons, mobile-element profiling, and strain fingerprinting.

A second resource, Chloramphenicol for Plasmid Selection Workflows, addresses laboratory management of selectable plasmids rather than CREC epidemiology. Its relevance here is operational: marker-based selection can help maintain engineered constructs during plasmid workflows, but it does not demonstrate carbapenemase transfer, clinical resistance, or hospital transmission. The Guangdong study’s conjugation and PCR experiments remain the evidence base for those claims.

Why this cross-domain matters, maturity, and limitations

Linking plasmid-selection practice with antimicrobial-resistance surveillance is useful because both domains depend on controlling plasmid maintenance and distinguishing stable inheritance from transfer. The bridge is mature for routine laboratory selection, but it is limited as an epidemiological model. A selectable laboratory plasmid is not equivalent to a clinical resistance plasmid, and selection conditions can alter which cells are recovered. Accordingly, molecular biology tools should support, not replace, clinical isolate characterization, susceptibility testing, and validated transfer assays.

Limitations and Transferability

The study provides a detailed snapshot, but several limitations affect how broadly the findings can be transferred. The isolate number was modest and restricted to teaching hospitals in one Chinese province. The data therefore describe a regional network and should not be treated as a national prevalence estimate or a universal profile of CREC.

Plasmid elimination is an indirect localization method. Loss of a PCR signal after SDS treatment supports plasmid association, but it may be influenced by incomplete curing, plasmid instability, or unintended effects on bacterial viability. Conjugation assays likewise measure transfer under defined laboratory conditions. They demonstrate capacity, not the rate of transmission between patients, wards, or hospitals.

ERIC-PCR is valuable for screening but has lower discriminatory power than high-resolution genomic approaches. The 17-genotype result should therefore be interpreted as evidence of relatedness at the method’s resolution rather than definitive proof of a single transmission chain. Whole-genome sequencing, closed plasmid assemblies, long-read linkage analysis, and longitudinal sampling could clarify whether identical resistance genes are carried by the same plasmid backbone.

Finally, the study is observational. The higher resistance rates in CEG-positive isolates and the concentration of detections in particular patient groups are associations within the collected sample. Future work should integrate patient movement, antimicrobial exposure, ward-level contact networks, and repeated environmental sampling. Even with these limitations, the paper supports a practical conclusion: surveillance should track both the bacterial clone and the mobile genetic vehicle.

Research Support Resources

For laboratory workflows requiring a selectable bacterial marker, researchers can use Chloramphenicol (SKU A2512), chemically 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide. As a bacterial protein synthesis inhibitor that targets the 50S ribosomal subunit, it can function as an antimicrobial agent in a plasmid selection assay and related molecular biology workflows. This chloramphenicol antibiotic reagent supports selection logic, but it does not by itself establish CEG localization, protein synthesis inhibition in the clinical isolate, or plasmid transfer; those conclusions require the molecular and phenotypic methods used in the reference study.